Mechanistic |
Cost/benefit decision making |
GABAa antagonist |
PFC |
Impaired decision making |
32
|
Physical/ cognitive effort |
Dopamine D1- or D2-family receptor antagonists |
Systemic |
Decreased physical effort, little effect on cognitive effort |
33
|
Cognitive effort |
THC/CB1 receptor agonist |
Systemic |
Decreased cognitive effort |
35
|
Reward learning |
Suppression of dopamine D1 receptor expression |
Striatum |
Impaired probabilistic learning; effort unaffected |
36
|
Physical effort |
Dopamine D1-family receptor antagonist |
ACC |
Impaired physical effort |
37
|
Physical effort |
Dopamine D2-family receptor antagonist |
Systemic |
Impaired physical effort |
38
|
Physical effort |
Dopamine D2 receptor overexpression |
Nucleus accumbens |
Increased physical effort expenditure |
39
|
Physical effort |
Dopamine D2 receptor overexpression |
striatum |
Impaired physical effort |
40,41
|
Physical effort |
GlyT1 inhibition |
N/A |
No effect |
52
|
Animal Models of Negative Symptoms |
Reward learning |
Knockout of α7 nicotinic acetylcholine receptors |
N/A |
Impaired probabilistic learning |
43
|
Physical effort |
Maternal immune activation |
N/A |
Increased breakpoints |
50
|
Physical effort |
Repeated phencyclidine |
N/A |
Increased breakpoint |
|
Reward learning |
Social Isolation Rearing |
N/A |
Impaired probabilistic reversal learning |
51
|
Physical effort |
Reduced Sp4 expression |
N/A |
Reduced physical effort |
53
|
Reward learning |
Reduced Sp4 expression |
N/A |
Impaired reward associative learning |
53
|
Reward learning |
Social defeat |
Striatum, VTA |
Blunted response bias |
54
|